Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Journal of the National Cancer Institute. Monographs|November 12, 2024
Evaluating potential program cost savings with a single-dose HPV vaccination schedule: a modeling studyRose Slavkovsky, Mercy Mvundura, Frédéric Debellut, et al.
Human Vaccines & Immunotherapeutics|March 4, 2022
Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: a modelling studyFrédéric Debellut, Clint Pecenka, William P Hausdorff, et al.
BMC Health Services Research|July 4, 2025
Cost-effectiveness and benefit-risk of rotavirus vaccination in Afghanistan: a modelling analysis informed by post-licensure surveillancePalwasha Anwari, Frédéric Debellut, Sardar Parwiz, et al.
Vaccine: X|August 26, 2024
Determinants of costs of human papillomavirus vaccine delivery in six low- and middle-income countriesMercy Mvundura, Rose Slavkovsky, Frédéric Debellut, et al.
BMC Public Health|May 7, 2020
Cost of illness for childhood diarrhea in low- and middle-income countries: a systematic review of evidence and modelled estimatesRanju Baral, Justice Nonvignon, Frédéric Debellut, et al.
Vaccine: X|December 5, 2024
Cost of the typhoid conjugate vaccine introduction through an integrated campaign and follow-on routine immunization in MalawiFrédéric Debellut, George Bello, Mike Chisema, et al.
Vaccines|February 26, 2022
Does Anybody Want an Injectable Rotavirus Vaccine, and Why? Understanding the Public Health Value Proposition of Next-Generation Rotavirus VaccinesWilliam P Hausdorff, Jessica Price, Frédéric Debellut, et al.
Plos One|June 23, 2018
Forecasting demand for maternal influenza immunization in low- and lower-middle-income countriesFrédéric Debellut, Nathaniel Hendrix, Justin R Ortiz, et al.
The Lancet. Global Health|April 23, 2021
Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling studyFrédéric Debellut, Andrew Clark, Clint Pecenka, et al.
BMJ Open|October 5, 2022
Impact and cost-effectiveness of rotavirus vaccination in Niger: a modelling study evaluating alternative rotavirus vaccinesFrédéric Debellut, Kevin Tang, Andrew Clark, et al.
Pageof 3